PEN
Penumbra IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$12.53B
P/E Ratio
73.56
EPS
$4.33
Beta
0.70
52W High
$362.41
52W Low
$221.26
50-Day MA
$325.67
200-Day MA
$306.26
Dividend Yield
—
Profit Margin
11.80%
Forward P/E
63.69
PEG Ratio
0.74
About Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.
Fundamentals
| Revenue (TTM) | $1.45B |
| Gross Profit (TTM) | $979.97M |
| EBITDA | $203.96M |
| Operating Margin | 10.20% |
| Return on Equity | 12.70% |
| Return on Assets | 6.70% |
| Revenue/Share (TTM) | $37.20 |
| Book Value | $37.48 |
| Price-to-Book | 8.57 |
| Price-to-Sales (TTM) | 8.67 |
| EV/Revenue | 8.41 |
| EV/EBITDA | 55.26 |
| Quarterly Earnings Growth (YoY) | -18.00% |
| Quarterly Revenue Growth (YoY) | 15.60% |
| Shares Outstanding | $39.33M |
| Float | $38.23M |
| % Insiders | 2.90% |
| % Institutions | 87.92% |
Historical Volatility
HV 10-Day
4.62%
HV 20-Day
10.73%
HV 30-Day
9.11%
HV 60-Day
9.53%
HV Rank
12.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($363.36 target)
2
Strong Buy2
Buy13
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026